Research On the Identification of Novel Antigens and The Optimization of Therapeutic Strategies in Cancer Immunotherapy Through Single-Cell Sequencing

With the advancement of single-cell sequencing, we are now capable of analyzing the heterogeneity within tumors with increased precision, revealing the complex interactions between the tumor microenvironment and immune cell subgroups. Studies mentioned in the articles demonstrate significant cell heterogeneity in various cancers at genomic, transcriptomic, and proteomic levels. In particular, single-cell technologies aid in identifying cell-type-specific genetic lineage effects, for example, in the context of influenza infection and T cell surveillance. Current study focuses on the application of single-cell sequencing in cancer immunotherapy and the exploration of novel antigen identification and optimization of therapeutic strategies. The introduction of new strategies, such as the refinement of electrochemical immuno-sensors, synthesis of novel small molecule drugs, and optimized detection of genetic mutations, contributes collectively to the accurate identification of tumor markers and innovative development of therapeutic methods. The integration of treatment schemes and patient survival analysis further guides the implementation of personalized medicine. In summary, the application of single-cell sequencing and its integration with the optimization of therapeutic strategies promises revolutionary advancements in the field of cancer immunotherapy.